AIDS

  • Part three of a three part series investigating environmental, corruption, and health concerns related to the $3.7 billion oil pipeline under construction in Chad and Cameroon. The pipeline, built by an international consortium, including the World Bank, ExxonMobil, and ChevronTexaco, is expected to begin pumping oil for the U.S. market by the end of 2003.

  • Many people who are infected with HIV are willing to try unproven treatments, some of which appear effective in maintaining health. But many discover that they have simply been duped or led astray by unscrupulous marketers. Reporter Sarah Henry explores the issue through the lens of Viroxan, an underground treatment that failed to provide the miracle cure it promised.

  • AIDS scams have become one of the most common kinds in the health care industry. Reporter Sarah Henry explores some of the unorthodox treatments that unscrupulous marketers peddle to desperate patients.

  • A North Hollywood doctor, accused of AIDS quackery, has been stripped of his medical license for his role in administering a homemade AIDS treatment linked by state authorities to four deaths and two more serious injuries.

  • An investigation into a growing trend by insurance companies and businesses to limit coverage for people with AIDS, Reporter Sarah Henry reveals that limited coverage is prompting sufferers of other terminal and chronic diseases to question the reliability of their health benefits.

  • An investigation into a growing trend by insurance companies and businesses to limit coverage for people with AIDS, Reporter Sarah Henry reveals that limited coverage is prompting sufferers of other terminal and chronic diseases to question the reliability of their health benefits. This CIR story was reprinted in the Metro Times and the Washington Post Health section.

  • An investigation into a growing trend by insurance companies and businesses to limit coverage for people with AIDS, Reporter Sarah Henry reveals that limited coverage is prompting sufferers of other terminal and chronic diseases to question the reliability of their health benefits. This CIR story was adapted from an article that appeared in The Nation.